Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Marrocco

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancers|October 28, 2023
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous MutatorsIlaria Marrocco, Yosef Yarden
Oxidative Medicine and Cellular Longevity|July 13, 2017
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in HumansIlaria Marrocco, Fabio Altieri, Ilaria Peluso
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Cancer Immunotherapy: The Dawn of Antibody CocktailsIlaria Marrocco, Donatella Romaniello, Yosef Yarden
International Journal of Molecular Sciences|April 17, 2025
Strategies to Overcome Resistance to Osimertinib in EGFR-Mutated Lung CancerDonatella Romaniello, Alessandra Morselli, Ilaria Marrocco
Advances in Cancer Research|June 29, 2020
Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatmentSoma Ghosh, Ilaria Marrocco, Yosef Yarden
Cancers|July 2, 2021
EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired ResistanceMary Luz Uribe, Ilaria Marrocco, Yosef Yarden
Biochemical Society Transactions|June 8, 2021
Roles for growth factors and mutations in metastatic disseminationNishanth Belugali Nataraj, Ilaria Marrocco, Yosef Yarden
Biochimie|February 10, 2018
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activityFlavia Giamogante, Ilaria Marrocco, Laura Cervoni, et al.
Oxidative Medicine and Cellular Longevity|January 4, 2017
Comparative Analysis of the Interaction between Different Flavonoids and PDIA3Flavia Giamogante, Ilaria Marrocco, Donatella Romaniello, et al.
Biochemical and Biophysical Research Communications|April 7, 2019
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodiesRuth Maron, Bilha Schechter, Nishanth Belugali Nataraj, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancers|October 28, 2023
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous MutatorsIlaria Marrocco, Yosef Yarden
Oxidative Medicine and Cellular Longevity|July 13, 2017
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in HumansIlaria Marrocco, Fabio Altieri, Ilaria Peluso
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Cancer Immunotherapy: The Dawn of Antibody CocktailsIlaria Marrocco, Donatella Romaniello, Yosef Yarden
International Journal of Molecular Sciences|April 17, 2025
Strategies to Overcome Resistance to Osimertinib in EGFR-Mutated Lung CancerDonatella Romaniello, Alessandra Morselli, Ilaria Marrocco
Advances in Cancer Research|June 29, 2020
Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatmentSoma Ghosh, Ilaria Marrocco, Yosef Yarden
Cancers|July 2, 2021
EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired ResistanceMary Luz Uribe, Ilaria Marrocco, Yosef Yarden
Biochemical Society Transactions|June 8, 2021
Roles for growth factors and mutations in metastatic disseminationNishanth Belugali Nataraj, Ilaria Marrocco, Yosef Yarden
Biochimie|February 10, 2018
Punicalagin, an active pomegranate component, is a new inhibitor of PDIA3 reductase activityFlavia Giamogante, Ilaria Marrocco, Laura Cervoni, et al.
Oxidative Medicine and Cellular Longevity|January 4, 2017
Comparative Analysis of the Interaction between Different Flavonoids and PDIA3Flavia Giamogante, Ilaria Marrocco, Donatella Romaniello, et al.
Biochemical and Biophysical Research Communications|April 7, 2019
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodiesRuth Maron, Bilha Schechter, Nishanth Belugali Nataraj, et al.
Pageof 3